Cellectar Biosciences Inc...

NASDAQ: CLRB · Real-Time Price · USD
4.37
-0.05 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
4.41
0.92%
After-hours: Aug 15, 2025, 07:05 PM EDT

Cellectar Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-44.58M -37.98M -28.6M -24.12M
Depreciation & Amortization
291.65K 192.38K 148.44K 149.91K
Stock-Based Compensation
4.27M 2.41M 1.45M 1.12M
Other Working Capital
-132.42K -224.39K 60.21K -212.96K
Other Non-Cash Items
-5.84M -471.95K 93.82K 77.72K
Deferred Income Tax
n/a n/a n/a 2.94K
Change in Working Capital
-1.73M 3.48M 1.68M 198.76K
Operating Cash Flow
-47.58M -32.38M -25.22M -22.57M
Capital Expenditures
-104.19K -864.04K -225.97K -141.36K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-104.19K -864.04K -225.97K -141.36K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -9.61M 1.21M
Financial Cash Flow
61.41M 22.94M 9.61M 1.25M
Net Cash Flow
13.72M -10.3M -15.84M -21.46M
Free Cash Flow
-47.69M -33.24M -25.45M -22.71M